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Abstract
A 12-year-old girl presented with a 4 year history of an enlarged, firm thyroid gland. On exam, her
thyroid was firm and fixed and an enlarged cervical lymph node was palpable as well. Though a
thyroid ultrasound prior to referral was read as thyroiditis, clinical suspicion for thyroid carcinoma
mandated continued investigation. The diagnosis of papillary thyroid cancer was established and her
workup revealed lymph node metastases as well as a tremendous burden of pulmonary metastases.
Pediatric thyroid cancer is extremely rare, but often presents with aggressive disease. Palpable
thyroid abnormalities in an individual under 20-years-old should be viewed with suspicion and
should be thoroughly investigated to rule out malignancy even in the face of negative diagnostic
procedures. Though pediatric papillary thyroid cancer often presents with loco-regional and even
distant metastatic disease, mortality rates in follow-up for as long as 20 years are very favorable.
Background
Thyroid cancer occurring under the age of 20 years is a
very rare occurrence with an incidence from 1975–1995
of < 2/100,000 children and adolescents. However, of epi-
thelial derived childhood carcinomas, thyroid cancer is
the most common [1]. Similar to adults, papillary thyroid
carcinoma is the most common of pediatric thyroid carci-
nomas representing 85–95% of cases. However, in con-
trast to adult papillary thyroid carcinoma, pediatric
papillary thyroid carcinoma tends to be more aggressive at
presentation with a higher incidence of multifocality,
neck lymph node disease and extracapsular extension
[2,3]. The following case details an aggressive presenta-
tion of pediatric papillary thyroid cancer and illustrates
the importance of vigilance in the context of an abnormal
thyroid physical exam in a child.
Case Report
A 12 year old female originally from El Salvador was
referred to the adult endocrinology clinic for a clinically
concerning thyroid gland. Per the patient and her
mother's history, her thyroid gland had been found to be
enlarged and firm by a physician for at least four years.
Several months prior to referral she had a thyroid ultra-
sound performed at a children's hospital and the report
impression was: "diffusely enlarged echogenic thyroid gland
consistent with thyroiditis, no masses".
The patient had no complaints. She denied local compres-
sive symptoms or dysphagia. She had no significant past
medical history. Her grandmother had surgery for a
benign goiter but there was no family history of thyroid
cancer and no personal history of head or neck irradia-
tion. She had normal vital signs with a blood pressure of
110/70, pulse of 100, and height of 58 inches with a
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weight of 92 pounds. Her exam was significant for a dif-
fusely enlarged thyroid gland of approximately 45 grams
with an irregular contour and a nodular thickening near
the isthmus on the left lobe. The thyroid was extremely
firm and fixed. Additionally, she had a 0.5–1 cm firm right
sided cervical lymph node near the upper pole of the thy-
roid. The rest of her physical exam was completely nor-
mal. Her TSH was 1.00 mcIU/mL and she had negative
anti-thyroid peroxidase and anti-thyroglobulin antibod-
ies. After informed consent was obtained, a fine-needle
aspiration biopsy of the left thyroid lobe near the isthmus
was performed. The cytology diagnosis was: "Benign
appearing follicular cells".
The patient was referred for repeat neck ultrasound by an
experienced thyroid ultrasound radiologist. He reported:
"A combination of abnormal thyroid gland features (punctate
echogenic foci) and the presence of bilateral abnormal lymph
nodes with punctate echogenic foci lateral to each internal jug-
ular vein is best explained by multi-focal papillary thyroid can-
cer and metastases to lymph nodes". Based on the ultrasound
report with localization of discrete suspicious areas of
papillary thyroid cancer within the thyroid gland and
abnormally large lymph nodes (some as large as 1.5 cm),
the patient was brought back to clinic and repeat thyroid
biopsy was performed. A diagnosis of papillary thyroid
cancer was made based upon the cytology (fig. 1a).
Prior to near-total thyroidectomy (NTT) and planned
radioactive iodine ablation therapy, the patient was sent
for a chest x-ray. The chest x-ray showed diffuse miliary
nodules throughout both lungs. A non-contrast chest CAT
scan was performed and this showed innumerable micro-
nodules throughout both lungs with a preponderance of
nodules in the lung bases (fig. 2).
The patient received a near-total thyroidectomy with cen-
tral neck dissection and modified bilateral neck dissec-
tion. During the procedure, the sternohyoid muscles were
resected on both sides of the thyroid and a small amount
of gross tumor was left on each recurrent laryngeal nerve
in lieu of sacrificing those structures. The patient had no
voice or breathing complications following the proce-
dure. No muscle groups were removed during the lateral
neck dissections. The final histology showed multifocal
invasive papillary carcinoma, follicular variant, involving
all thyroid lobes with a greatest diameter of 4.7 cm (fig.
1b). There was extracapsular invasion and positive surgi-
cal margins with involvement of the thymus noted as well
as angiolymphatic invasion. One of three level six central
neck lymph nodes were positive for disease as were 9/48
and 9/38 lymph nodes on the left and right neck dissec-
tions respectively with no specific delineation of levels
two through four lymph node groups. Though only two
parathyroid glands were identified on final histology, the
patient unfortunately suffered the operative complication
of hypoparathyroidism.
In preparing the patient for radioactive iodine ablation,
an empiric dose of 200 mCi was considered. With con-
cerns of potential pulmonary fibrosis, dosimetry was per-
formed to assess the maximum dose that would be
tolerated without pulmonary damage. Two millicuries of
131I were administered orally and 48 hours later the
patient returned for a whole body scan (WBS) and uptake
analysis in the lungs. The WBS showed multiple foci of
uptake bilaterally in the base of the neck and diffuse
uptake in the lungs with basilar prominence bilaterally.
The stimulated thyroglobulin level was > 13,000 ng/mL
indicating a tremendous burden of pulmonary thyroid
cancer. The lung uptake was estimated to be 45% and
based on geometric mean calculation determined by pro-
prietary software, 150 mCi was considered to be the max-
imum tolerated dose that would most likely avoid
radiation induced pulmonary fibrosis and was given two
weeks later. Her post-therapy scan one week after the 150
mCi of 131I showed uptake just left of the midline in the
base of the neck as well as extensive pulmonary uptake of
the radioactive iodine (fig. 3). The patient did not suffer
any complications after her radioiodine.
Discussion
Pediatric thyroid cancer is rare. Risk factors include a fam-
ily history and previous radiation exposure [4]. The
patient presented, however, had no identifiable risk fac-
tors. Sporadic papillary thyroid cancer represented only
1.4% of newly diagnosed childhood carcinomas in the
USA from 1975–1995 according to the SEER database [5].
Interestingly, the incidence among gender lines changes
according to age group with males having a 6:1 increased
incidence at ages 5–9, a similar incidence among males
and females from ages 10–14 and a ratio more consistent
with adult patients with 5:2 female to male ratio after age
14 [5].
Palpable thyroid abnormalities are rare in childhood and
should be approached with suspicion and an aggressive
evaluation. The incidence of thyroid nodules in children
before the onset of puberty is less than two percent in
iodine sufficient areas and the aggregate risk of thyroid
cancer in a pediatric thyroid nodule can surpass 25% [6].
Our patient had an abnormal thyroid exam for as long as
four years prior to being seen in our clinic. The family was
unsure of any discrete nodule noted in the past. In this
case, the thyroid cancer was diffusely spread through the
patient's gland as described and therefore no discrete nod-
ule was present at our initial exam.
The gold standard diagnostic test to define thyroid lesions
is fine needle aspiration (FNA) biopsy. Cytological analy-Journal of Medical Case Reports 2007, 1:29 http://www.jmedicalcasereports.com/content/1/1/29
Page 3 of 5
(page number not for citation purposes)
sis has been evaluated in the pediatric population though
the data is somewhat limited by the far less frequent
occurrence of pediatric thyroid nodules and FNA biopsies.
In a series of 101 specimens from 82 pediatric patients,
the diagnostic sensitivity and specificity of detecting carci-
noma were 87% and 92% respectively [6,7]. The initial
biopsy in this case was read as benign. Based on the con-
cerning clinical features, we simply did not believe that
the FNA material was representative of the disease state. It
is likely that since there was no discrete nodule the needle
simply was not targeted to a malignant portion of the
gland. Although an ultrasound guided FNA of an abnor-
mal lymph node would have been an appropriate next
step, scheduling difficulties made a second palpation
guided FNA after evaluation of the US a better option.
Again, the vigilance that is appropriate for pediatric thy-
roid abnormalities pushed us to continue the pursuit of a
clinically suspicious diagnosis. The second FNA con-
firmed papillary thyroid cancer.
Thyroid ultrasound now plays a prominent and expand-
ing role in the evaluation of thyroid nodules. In a study of
patients all under the age of 18 years, thyroid nodule
ultrasound features including irregular borders and
increased vascular flow assessed by power doppler had
positive predictive value for thyroid cancer nodules under
15 mm [8]. The importance of thyroid ultrasound experi-
ence cannot be stressed enough in the evaluation of a thy-
roid gland that is clinically suspicious for a nodule or
malignant process. The initial US in this case occurred in
a children's hospital where these studies are not routinely
performed. Our expert thyroid ultrasound radiologist
immediately noted the concerning features for malig-
nancy of echogenic foci (microcalcifications) in the thy-
roid as well as the same features in enlarged lateral neck
lymph nodes [9].
Extensive lymph node disease at the time of diagnosis of
pediatric papillary thyroid cancer is not a surprising find-
ing. For adults diagnosed between the ages of 30–60,
regional cervical and upper mediastinum lymph node
metastases occur in 38–43% of patients [10]. In pediatric
patients (age < 21 years old), however, regional nodal
metastases occur in 60–80% of cases [3]. We chose to eval-
uate for distant metastases in this patient's course to help
prepare a post-surgical treatment plan. Distant metastases
in adult well differentiated papillary thyroid cancer are
rare, occurring in only 2–4% of patients at the time of
diagnosis [10]. The pediatric population however has dis-
tant parenchymal metastases (most often lung) in 10–
20% of cases at diagnosis [3].
The assessment of pulmonary metastases prior to radioac-
tive iodine therapy has important implications for choos-
ing a treatment dose and avoiding toxicity, especially
pulmonary fibrosis. In children, dosimetry is preferred to
assess a safe maximum dose to ideally keep the blood
dose of 131I < 200–300 cGy and the pulmonary dose to <
80 mCi to avoid pulmonary fibrosis [4]. Our institution
does not routinely utilize dosimetry for choosing an adult
a. Cytology consistent with papillary thyroid cancer including nuclear size variation, microfollicle cellular arrangement and an  intranuclear pseudo-inclusion (arrow) Figure 1
a. Cytology consistent with papillary thyroid cancer including nuclear size variation, microfollicle cellular arrangement and an 
intranuclear pseudo-inclusion (arrow). Papanicolaou stain at 400× magnification. b. Final histology showed a papillary carci-
noma, follicular variant. There are characteristic nuclear features including ground glass nuclei, inconspicuous nucleoli, thick-
ened nuclear membranes, nuclear pseudoinclusions, and nuclear grooves. This slide also shows a psammoma body. 
Hematoxylin & Eosin stain at 200× magnification.
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dose of 131I for well differentiated thyroid cancer and we
considered giving an empiric dose of 200 mCi to this
child. However, dosimetry was appropriately pursued by
our nuclear medicine physicians and a dose of 150 mCi
was felt to be the safe tolerable dose from a pulmonary
safety standpoint.
With such aggressive presentations of pediatric papillary
thyroid cancer, one may think that there is excessive mor-
tality. This is not the case. In a retrospective analysis of 14
patients under the age of 17 years diagnosed with sporadic
papillary thyroid cancer, all of whom had pulmonary
metastases at the time of diagnosis or within 6 months of
diagnosis, there was 100% survival over a mean 19 year
follow up [2]. Although there is not a high mortality rate,
these patients do suffer significant morbidity with a high
recurrence rate of their thyroid cancer that requires either
multiple surgeries and/or doses of radioactive iodine, as
well as long term thyroid hormone suppressive therapy
[4].
Conclusion
Pediatric papillary thyroid cancer can have a very aggres-
sive initial presentation including a high rate of local
lymph node metastases and relatively high rate of distant
metastases compared to adult patients. Although a life-
time recurrence rate is high, the mortality rates are still
low. Palpable thyroid abnormalities in children should be
CT scan of the chest that cuts from the apices (1) to the lung bases (4) and shows tremendous tumor burden as well as a basi- lar prominence of metastases typical of papillary thyroid carcinoma lung metastases Figure 2
CT scan of the chest that cuts from the apices (1) to the lung bases (4) and shows tremendous tumor burden as well as a basi-
lar prominence of metastases typical of papillary thyroid carcinoma lung metastases.
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viewed with suspicion and worked up aggressively for
possible malignancy even in the face of initially negative
diagnostic testing.
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Post-Therapy scan after 150 mCi 131I Figure 3
Post-Therapy scan after 150 mCi 131I. This anterior view 
shows tremendous bilateral pulmonary uptake of radioactive 
iodine, so much so that it visually obliterates the neck uptake 
detected as well.